NanoSanguis is a company founded to bring to the market first safe and effective red blood cell substitute. The company has its origin in Warsaw University of Technology. We have started as a team of PhD candidates developing technology of oxygen therapeutics. In December 2015, together with two VC capitals – Start Venture Poland and Giza Polish Ventures, we created NanoSanguis to give synthetic blood every human in need regardless of their origin, social status and religious beliefs.
View Top Employees from NanoSanguis, Inc.Website | http://nanosanguis.com/ |
Revenue | $7.6 million |
Employees | 7 (4 on RocketReach) |
Founded | 2015 |
Address | 36 Rakowiecka, Warsaw, Masovian Voivodeship 02-532, PL |
Technologies |
JavaScript,
HTML,
PHP
+3 more
(view full list)
|
Industry | Biotechnology, Business Services General, Business Services, Science and Engineering |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies |
Looking for a particular NanoSanguis, Inc. employee's phone or email?
The NanoSanguis, Inc. annual revenue was $7.6 million in 2024.
Paweł Ciach is the Member of the Supervisory Board of NanoSanguis, Inc..
4 people are employed at NanoSanguis, Inc..
NanoSanguis, Inc. is based in Warsaw, Masovian Voivodeship.
The NAICS codes for NanoSanguis, Inc. are [54171, 54, 541713, 5417, 541].
The SIC codes for NanoSanguis, Inc. are [873, 87].